Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
Esther Moga, Elionor Lynton-Pons, Peré Domingo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study
Gili Regev‐Yochay, Yaniv Lustig, Gili Joseph, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e309-e318
Open Access | Times Cited: 66
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
Helen R. Wagstaffe, Ryan S. Thwaites, Arnold Reynaldi, et al.
Science Immunology (2024) Vol. 9, Iss. 92
Open Access | Times Cited: 25
Adaptive immunity to SARS-CoV-2 infection: A systematic review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity
Alexander Muik, Bonny Gaby Lui, Jasmin Quandt, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112888-112888
Open Access | Times Cited: 23
Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies
Zainab Shahid, Tania Jain, M. Veronica Dioverti, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 10, pp. 955-969
Open Access | Times Cited: 10
The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
Konstantin Föhse, Büsra Geckin, Martijn Zoodsma, et al.
Clinical Immunology (2023) Vol. 255, pp. 109762-109762
Open Access | Times Cited: 19
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID
Tamás Constantin, Tamás Pék, Zsuzsanna Horváth, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2221-2236
Open Access | Times Cited: 17
Identification and mechanism analysis of biomarkers related to butyrate metabolism in COVID-19 patients
Wenchao Zhou, Hui Li, Juan Zhang, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
SARS-CoV-2 infection and immune responses
Rakhi Harne, Brittany Williams, Hazem F. M. Abdelaal, et al.
AIMS Microbiology (2023) Vol. 9, Iss. 2, pp. 245-276
Open Access | Times Cited: 11
Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome
А. А. Савченко, I. V. Kudryavtsev, Dmitry Isakov, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 537-537
Open Access | Times Cited: 9
Flublok Quadrivalent Vaccine Adjuvanted with R-DOTAP Elicits a Robust and Multifunctional CD4 T Cell Response That Is of Greater Magnitude and Functional Diversity Than Conventional Adjuvant Systems
Chantelle L. White, Maryah A. Glover, Siva K. Gandhapudi, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 281-281
Open Access | Times Cited: 2
Combining SARS‐CoV‐2 interferon‐gamma release assay with humoral response assessment to define immune memory profiles
William Mouton, Guy Oriol, Christelle Compagnon, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 7
Closed Access | Times Cited: 2
Immunophenotype of lymphocytes and real-world outcome of COVID-19 infection in children with hematology and oncology
Na Zhang, Zhen Wang, Hong Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Purification technology design, biochemical and immunological characteristics of the recombinant chimeric antigen for evaluation of T cell immunity against coronavirus infection
V. V. Kopat, A. A. Riabchenkova, E. L. Chirak, et al.
Medical Immunology (Russia) (2024) Vol. 26, Iss. 3, pp. 591-606
Open Access | Times Cited: 2
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes
Alexander Muik, Bonny Gaby Lui, Huitian Diao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients
Nina Körber, Christopher Holzmann‐Littig, Gesa Wilkens, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Symptomatic MERS-CoV infection reduces the risk of future COVID-19 disease; a retrospective cohort study
Aiman El‐Saed, Fatmah Othman, Henry Baffoe-Bonnie, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac
Diego A. Díaz-Dinamarca, Simone Cardenas-Cáceres, Nicolás A. Muena, et al.
(2024)
Open Access | Times Cited: 1
Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States
Chad R. Wells, Abhishek Pandey, Seyed M. Moghadas, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 5, pp. 609-617
Closed Access | Times Cited: 1
Low Number of Baselines γδ T Cells Increase the Risk of SARS-CoV-2 Post-Vaccination Infection
Juan Carlos Andreu‐Ballester, Lorena Galindo-Regal, Carmen Cuéllar, et al.
(2024)
Open Access | Times Cited: 1
COVID-19 in kidney transplantation-implications for immunosuppression and vaccination
Lavanya Kodali, Pooja Budhiraja, Juan Gea‐Banacloche
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020-2022)
Salvador Domènech-Montoliu, Joan Puig‐Barberà, Gemma Badenes-Marques, et al.
(2023)
Open Access | Times Cited: 4
Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020–2022)
Salvador Domènech-Montoliu, Joan Puig‐Barberà, Gema Badenes-Marques, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1590-1590
Open Access | Times Cited: 4
Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2
Antonio J. Martín-Galiano, Daniel López
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6087-6087
Open Access | Times Cited: 1
Determinants of protection against SARS‐CoV‐2 Omicron BA.1 and Delta infections in fully vaccinated outpatients
Álvaro Roy, Carla Saade, Laurence Josset, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top